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Abstract
Patients with general malaise or feeling non-specifically unwell is a common scenario 
faced by all doctors. This case study reviews the made up case of an elderly male 
with these symptoms presenting to his primary care practitioner and his subsequent 
management in hospital. An evidence based clinical question and discussion of the 
ethical and personal impact of the case is also presented.
Note: This article is based on the Knol entitled “Common Cases: General malaise 
in an elderly male patient” accessed through http://knol.google.com/k/w-kent/
common-cases-general-malaise-in-an/1blm6ty1i8a7z/6?collectionId=1bbsle13m9
7c0.391# on the 4th July 2011.
Presenting problem & summary  
of history
 
PC: General malaise for 3/12
HPC: This 73 year old male presented to his GP with undif-
ferentiated symptoms and non-specific complaints of feeling 
of general malaise. He had been a frequent attendee to his GP 
since the recent tragic death of his sister-in-law. The GP had 
started Mr C on an antidepressant but also thought it prudent 
to request a blood screen, because the patient had not had a 
blood test for 3 years. 
The blood tests revealed an elevated potassium level (7.2 
mmol/l) and the GP organised admission to hospital. Despite 
this high potassium Mr C denied any symptoms of chest pain, 
palpitations, shortness of breath, nausea and vomiting, weak-
ness, or urinary symptoms. He also denied dietary supplemen-
tation of potassium or use of any drugs with known hyperka-
laemic side effects. A systems review revealed nil of note.
 
PMH: He had known:
1. Gout, 
2. Hypertension, &
3. Depression.
 
DH: NKDA
Drug Dose/frequency Indication Prescriber
Allopurinol 200 mg / od Gout prophylaxis GP
Venaflaxine 75 mg / od Depression GP
Indomethacin
500 mg/ tds / 
(PRN)
Only during acute 
gout (none taken for 
>3/12)
GP
Inderal LA 160 mg / od Hypertension GP
Atorvastatin 40 mg / od Elevated cholesterol GP
On admission:
FH: Nil of note.
 
SH: Mr C is a retired printer is independently mobile and lives 
with his wife in their privately owned house with 1 flight of 
stairs. He is an occasional drinker (<21 units/week) but denies 
ever smoking. 
Examination findings
 
On examination Mr C was a well-built man who looked well, he 
was in no obvious discomfort and was alert (GCS 15/15) and ori-
entated in time and space (AMT 10/10). His blood pressure was 
elevated at 191/91 mmHg but all his other vital observations 
were normal (apyrexial 37.6oC, heart rate 62 bpm, saturations 
99% on air) and there were no clinically evident peripheral 
stigmata of disease (no jaundice, anaemia, clubbing, cyanosis, 
oedema, lymphadenopathy or goitre).
iMedPub Journals
This article is available from: http://www. ojmedicine.com OPEN JOURNAL OF MEDICINE
2011
Vol. 1 No. 1:1
doi: 10:3823/500
2 © Copyright iMedPub
A cardiovascular examination revealed good perfusion, no 
signs of dehydration, normal heart sounds and peripheral 
pulses were palpable and no abdominal bruits were audible. 
A respiratory, gastrointestinal and neurological examination 
also failed to detect any abnormalities.  
 
Summary: A retired 73-year-old male with known hyperten-
sion, gout and depression presented with a 3/12 history of gen-
eral lethargy and malaise. Physical examination was normal 
apart from hypertension (191/91 mmHg). A screening blood 
test revealed hyperkalaemia (7.2 mmol/l). 
Differential diagnoses
 
Causes of hyperkalaemia can be classified by pathophysiologi-
cal mechanism into increased potassium intake, decreased 
potassium excretion or intracellular to extracellular shift of 
potassium.1 Decreased excretion is by far the most common 
underlying mechanism and the most common cause is the 
use of drugs affecting the renin-angiotensin system frequently 
combined with some degree of renal impairment, followed by 
other independent predictors of elevated serum potassium 
such as diabetes mellitus. Other unusual causes such as my-
eloma, increased ingestion of potassium, type IV renal tubular 
acidosis, and abnormalities of steroid metabolism should only 
be sought once more common causes are excluded.
 
Investigations
Bloods:
•  Haematological: FBC (check for anaemia and type which 
may indicate or support underlying cause e.g. normocytic, 
normochromic in acute haemolysis or anaemia of chronic 
disease in chronic renal failure).
Biochemistry:
•  U&Es & Cr level (assess renal function and degree of hyper-
kalaemia and to rule out a spurious result).
•  Ca2+ level (in renal failure hypocalcaemia can exacerbate 
cardiac arrythmia potential).
•  Glucose level to check for DM.
Urinalysis:
•  Urine dip.
•  Check volume and electrolytes.
Radiology:
•  USS KUB (to screen for structural abnormalities and renal ar-
tery stenosis as a cause of impaired renal function).
ECG:
•  Allow assessment of intracellular potassium & monitoring of 
patient.
 
Other tests: 
•  Fundoscopy (was performed to screen for end organ dam-
age from hypertension).
•  A “myeloma screen’ (FBC, ESR, serum & urine electrophoresis, 
renal function tests & bone profile) was also carried out in this 
patient to rule out myeloma leading to renal dysfunction and 
subsequent hyperkalaemia.  
 
The investigations confirmed the hyperkalaemia (7.1 mmol/l), 
and demonstrated impaired renal function (urea 23.5, Cr 494, 
eGFR 10) and marginal hypocalcaemia (2.14) as well as anaemia 
(Hb 9 g/dl). The urine dip was negative for infection but total 
urine protein was 2.46 g/l. fundoscopy revealed mild hyper-
tensive retinopathy. The myeloma screen was negative but the 
ECG showed characteristic changes associated with hyperka-
laemia (small p waves, broad QRS, and tall tented T waves). The 
voltage criteria for left ventricular hypertrophy was also ful-
filled presumably due to the patients long standing hyperten-
sion. Interestingly the USS KUB reported a normal right kidney 
but the left kidney could not be identified and after discussion 
with the regional renal unit a renal MRA was ordered. 
 
Management
 
Despite not having overt symptoms according to the hyperka-
laemia guidelines a potassium levels of 7.1 mmol/l is classified 
as severe and there was ECG changes, both of which are inde-
pendent indicators for urgent treatment. [1,2] 
 
Urgent treatment involved placing the patient on telemetry 
and giving 10ml of 10% calcium gluconate over 2 minutes to 
protect the cardiac membrane and prevent fatal arrhythmia. 
The next step is to shift potassium into cells using followed by 
insulin-glucose IV (10 units Actrapid in 50ml of glucose 50%) 
infused over 30 minutes and salbutamol 10mg by nebuliser. 
The final stage was to remove potassium from the body using 
calcium polystyrene sulphonate resin (calcium resonium) with 
regular lactulose to remove potassium from the GI tract. 
Clinical decision making
 
Assessment of the patient involves1,2:
Questions This case
1. Confirm true hyperkalaemia Yes (by repeat bloods)
2. How severe is the hyperkalaemia? Severe (>7mmol/l)
3. Is urgent treatment required? Yes (>7mmol/l & ECG changes)
4.  Why has this patient got 
hyperkalaemia
Full history, examination & 
investigation (Acute on chronic renal 
failure, secondary to hypertension)
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Evidence base
 
What is the risk of a 73 year-old nondiabetic male 
with hypertensive chronic kidney disease (CKD) 
developing hyperkalaemia?
 
The reported incidence of hyperkalaemia (K+ > 5.5 mmol/l) in 
hospitals varies between 1-10%, and it is most prevalent at the 
extremes of life.1,2 It is an important diagnosis to consider and 
make because it is potentially life threatening, mortality rates 
can be as high as 67% if severe hyperkalaemia is not rapidly 
treated.[3]
 
In a study[4] randomly allocating 1094 male nondiabetic par-
ticipants with hypertensive CKD to ACE inhibitor (ACEi), Beta 
blocker (BB), or dihydropyridine calcium channel blocker (CCB) 
therapy it was found that the risk of hyperkalaemia was small, 
especially if the GFR was higher than 40mL/min/1.73m2. Dur-
ing the study 80 events (K+ >5.5 mmol/l) in 51 participants 
were recorded. The risk of hyperkalaemia was higher in the 
ACEi group compared with those taking CCB (HR, 7.00; 95% 
CI, 2.29-21.39 [P < .001]) or BB (HR, 2.85; 95% CI, 1.50-5.42 [P = 
.001]). The hazard ratio (HR) for hyperkalemia also varied with 
GFR. In patients with a GFR between 31 and 40 mL/min/1.73 
m(2) and a GFR lower than 30 mL/min/1.73 m(2) was 3.61 (95% 
confidence interval [CI], 1.42-9.18 [P = .007]) and 6.81 (95% CI, 
2.67-17.35 [P < .001]), respectively. However, there was no in-
creased risk of hyperkalemia if GFR was 41 to 50 mL/min/1.73 
m(2). Interestingly a secondary finding was that concomitant 
dieuretic therapy was associated with a 59% reduction of hy-
perkalaemia. 
 
These results suggest that the risk of hyperkalaemia is low and 
the use of diuretic therapy deserves further investigation in 
the management of nondiabetic men with hypertensive CKD.
Effect of illness episode on patient and 
family/carers
 
The patient was cheerful throughout his admission and was 
very interested in his management and the possible reasons 
for his hyperkalaemia, especially as he did not feel unwell. He 
was well supported by his wife and after a few days in hospital 
for investigation he was very keen to return home. Although 
he was intrigued to find out more about his absent left kidney. 
Ethical / governance issues:
 
Is this case the GP ordered blood tests without a definite ques-
tion in mind for the tests to answer. The use of investigations in 
this manner has been critisised as potentially wasteful because 
it does not follow guidelines.[5] However, the results were 
potentially life saving for this individual, who had a marked 
changes on his ECG secondary to servere hyperkalaemia. Thus, 
the use of blood tests in this situation was justified and shows 
the value of doctors acting on experience and clinical suspi-
cion. 
 
Summary
 
The urgent management of hyperkalaemia is an important 
topic for physicians because of the risk of mortality from car-
diac arrythmias associated with the condition. This case study 
presents both population level guideline evidence and evi-
dence based practice focused on the individual patient. It is 
hoped that by reading this article medical students are more 
confident in the initial assessment and management of hyper-
kalaemia.
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